Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 24, 2021
Windtree is extending its collaboration with the University of Milan-Bicocca for the discovery and development of new SERCA2a compounds for the potential treatment of chronic and acute human heart failure.
read more
Wednesday, March 24, 2021
Alcami announced its Board of Directors has appointed Patrick D. Walsh as Chairman and Chief Executive Officer, effective immediately.
read more
Wednesday, March 24, 2021
PerkinElmer announced documentation, workflow and decision-making Signals informatics platform is being expanded to build on existing capabilities in the biologics drug discovery space.
read more
Novo Nordisk and TetraScience have announced a new partnership to design a cloud-based instrument data platform for drug R&D, built natively on Amazon Web Services.
read more
PPL's, Piramal Pharma Solutions, announced the Company has entered into a Master Services Agreement.
read more
Catalent has signed an agreement with Cybin to apply Catalent’s proprietary Zydis ODT technology for the delivery of Cybin’s novel deuterated tryptamine.
read more
Zydus is recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials after receiving several complaints of crystallization in vials.
read more
Thermo Fisher Scientific announced a strategic technology collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher’s standardized COVID-19 Testing Platform.
read more
Worldwide Clinical Trials announced Sherilyn Adcock, RPH, PHD, has been promoted to chief scientific officer, Early Phase Development.
read more
Abveris announced the release of antibody sequences specific to the SARS-CoV-2 spike (S) protein into the public domain for unrestricted use.
read more
PsyBio Therapeutics has initiated process development of its proprietary biosynthetic formulation of norbaeocystin in collaboration with the Advanced Biofuels and Bioproducts Process Development Unit.
read more
The FDA has proposed to include one additional bulk drug substance on the list of bulk drug substances that outsourcing facilities may use in drug compounding consistent with section 503B of the Federal Food, Drug and Cosmetic Act.
read more
TrialScope has been selected by H. Lundbeck A/S as its partner for maintaining disclosure compliance.
read more
Gamma Biosciences has announced two additions to the senior management team of Astrea Bioseparations.
read more
CyanVac announced they have selected Exothera for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector.
read more